Does a High-Risk (gt;1/50) Result for First-Trimester Combined Screening Always Entail Invasive Testing? Which Patients from This Group Might Benefit from cfDNA Testing?

Autor: Rocío García-Jiménez, Irene Valero, Isabel Corrales-Gutiérrez, Reyes Granell, Carlota Borrero, José Antonio Sainz-Bueno

Publikováno v: Biomedicines; Volume 10; Issue 10; Pages: 2579

Currently, cell-free DNA (cfDNA) is offered as part of a contingent screening for patients with a first-trimester combined test (FCT) risk between 1/50 and 1/250. However, most aneuploidies are within the group of patients with a risk above 1/10. An

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78587e2f7b0a4534c96e416eca6dcf29
https://pubmed.ncbi.nlm.nih.gov/36289845

Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study

Autor: Virginia Engels Calvo, Sara Cruz Melguizo, Alejandra Abascal-Saiz, Laura Forcén Acebal, Amalia Sánchez-Migallón, Pilar Pintado Recarte, Celia Cuenca Marín, Beatriz Marcos Puig, Pablo G. Del Barrio Fernández, Olga Nieto Velasco, María Luisa de la Cruz Conty, Oscar Martínez-Perez, María Belén Garrido Luque, Camino Fernández Fernández, Ana Villalba Yarza, Esther María Canedo Carballeira, María Begoña Dueñas Carazo, Rosario Redondo Aguilar, Ángeles Sánchez-Vegazo García, Esther Álvarez Silvares, María Isabel Pardo Pumar, Macarena Alférez Álvarez-Mallo, Víctor Muñoz Carmona, Noelia Pérez Pérez, Cristina Álvarez Colomo, Onofre Alomar Mateu, Claudio Marañon Di Leo, María del Carmen Parada Millán, Adrián Martín García, José Navarrina Martínez, Anna Mundó Fornell, Elena Pascual Salvador, Tania Manrique Gómez, Marta Ruth Meca Casbas, Noemí Freixas Grimalt, Adriana Aquise, María del Mar Gil, Eduardo Cazorla Amorós, Alberto Armijo Sánchez, María Isabel Conca Rodero, Ana Belén Oreja Cuesta, Cristina Ruiz Aguilar, Susana Fernández García, Mercedes Ramírez Gómez, Esther Vanessa Aguilar Galán, Rocío López Pérez, Carmen Baena Luque, Luz María Jiménez Losa, Susana Soldevilla Pérez, María Reyes Granell Escobar, Manuel Domínguez González, Flora Navarro Blaya, Juan Carlos Wizner de Alva, Rosa Pedró Carulla, Encarnación Carmona Sánchez, Judit Canet Rodríguez, Eva Morán Antolín, Montse Macià, Laia Pratcorona, Irene Gastaca Abásolo, Begoña Martínez Borde, Óscar Vaquerizo Ruiz, José Ruiz Aragón, Raquel González Seoane, María Teulón González, Lourdes Martín González, Cristina Lesmes Heredia, J. Román Broullón Molanes, María Joaquina Gimeno Gimeno, Alma María Posadas San Juan, Otilia González Vanegas, Ana María Fernández Alonso, Lucía Díaz Meca, Alberto Puerta Prieto, María del Pilar Guadix Martín, Carmen María Orizales Lago, José Antonio Sainz Bueno, Mónica Catalina Coello, María José Núñez Valera, Lucas Cerrillos González, José Adanez García, Elena Ferriols-Pérez, Marta Roqueta, María Begoña Encinas Pardilla, Marta García Sánchez, Laura González Rodríguez, Elena Pintado Paredes, Paola Carmona Payán, Yosu Franco Iriarte, Luis San Frutos Llorente

Publikováno v: Fertility and Sterility

Objective To evaluate the perinatal and maternal outcomes of pregnancies in SARS-CoV-2 infected women, comparing spontaneous and In Vitro Fertilization (IVF) pregnancies (with either own or donor oocytes). Design Multicentre, prospective, observation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3589e145258c15ba28357eba14d85c68
https://pubmed.ncbi.nlm.nih.gov/34332751

Clinical and Economic Evaluation after Adopting Contingent Cell-Free DNA Screening for Fetal Trisomies in South Spain

Autor: Manuel Vargas, María R Torres, M. M. Gil, José Antonio Sainz, Pilar Carrasco, Belén Santacruz, Ignacio Peral, José Antonio García-Mejido, Reyes Granell

Publikováno v: DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
DDFV: Repositorio Institucional de la Universidad Francisco de Vitoria
Universidad Francisco de Vitoria

Introduction: Contingent cell-free (cf) DNA screening on the basis of the first-trimester combined test (FCT) results has emerged as a cost-effective strategy for screening of trisomy 21 (T21). Objectives: To assess performance, patients’ uptake, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a20e66fc4f4cd70a596cb38a9465b872

Fast protocol for the diagnosis of lysosomal diseases in nonimmune hydrops fetalis

Autor: Gema Fernández, Aurora Sánchez, M. José Coll, Laura Gort, M. Reyes Granell, Práxedes Carreto

Publikováno v: Prenatal Diagnosis. 32:1139-1142

Objective Nonimmune hydrops fetalis (NIHF) is defined by the excessive fluid accumulation in more than one foetal compartments and body cavities because of nonimmune reasons. It has been described that 14 lysosomal diseases may be causative of NIHF.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bb1695a25a91442e15824b0a6a5a5dca
https://doi.org/10.1002/pd.3972

Fast protocol for the diagnosis of lysosomal diseases in nonimmune hydrops fetalis

Autor: Laura, Gort, M Reyes, Granell, Gema, Fernández, Práxedes, Carreto, Aurora, Sanchez, M José, Coll

Publikováno v: Prenatal diagnosis. 32(12)

Nonimmune hydrops fetalis (NIHF) is defined by the excessive fluid accumulation in more than one foetal compartments and body cavities because of nonimmune reasons. It has been described that 14 lysosomal diseases may be causative of NIHF. The aim of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::eec5daf2bc3ca707cd03f45ba7a7daca
https://pubmed.ncbi.nlm.nih.gov/22991067